Literature DB >> 19902201

Association of TNFAIP3 polymorphism with rheumatic heart disease in Chinese Han population.

Rong Hua1, Ji-bin Xu, Jiu-cun Wang, Li Zhu, Bing Li, Yang Liu, Sheng-dong Huang, Li Jin, Zhi-yun Xu, Xiao-feng Wang.   

Abstract

In a pair-matched case-control study (239 versus 478) conducted in Chinese Han population, we investigated the association between tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene, tumor necrosis factor receptor-associated factor 1 (TRAF1) gene, complement component 5 (C5) gene, and rheumatic heart disease (RHD). We observed no association with RHD for the five tagging single nucleotide polymorphisms (tSNP) in the C5 gene, the three tSNPs in the TNFAIP3 gene, or the two tSNPs in the TRAF1 gene. However, we determined that the tSNP, rs582757, located at intron_5 of the TNFAIP3 gene, associated with RHD in Chinese Han population. Both the distribution of genotype and allele frequencies differed significantly between case and control subjects (p = 0.001 and p = 0.0004, respectively). The minor C allele reduced the risk of RHD with a per-allele odds ratio of 0.57 (0.42-0.78) for the additive model in univariate analysis (p = 0.000). Under a dominant model, CC/CT carriers had a 0.54-fold reduced risk of RHD (95% confidence interval 0.38-0.75, p = 0.000) than TT carriers. Therefore, we report a new genetic variant (rs582757) in the TNFAIP3 gene that associated with the prevalence of RHD in Chinese Han population. Further genetic and functional studies are required to identify the etiological variants in linkage disequilibrium with this polymorphism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902201     DOI: 10.1007/s00251-009-0405-8

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  30 in total

1.  SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery.

Authors:  Peter A Bell; Surendra Chaturvedi; Craig A Gelfand; Ching Yu Huang; Michael Kochersperger; Rafael Kopla; Frank Modica; Mark Pohl; Shobha Varde; Renbin Zhao; Xiaojian Zhao; Michael T Boyce-Jacino; Azzam Yassen
Journal:  Biotechniques       Date:  2002-06       Impact factor: 1.993

2.  An immunological cross-reaction between group-A streptococcal cells and human heart tissue.

Authors:  M H KAPLAN; M MEYESERIAN
Journal:  Lancet       Date:  1962-04-07       Impact factor: 79.321

3.  Two independent alleles at 6q23 associated with risk of rheumatoid arthritis.

Authors:  Robert M Plenge; Chris Cotsapas; Leela Davies; Alkes L Price; Paul I W de Bakker; Julian Maller; Itsik Pe'er; Noel P Burtt; Brendan Blumenstiel; Matt DeFelice; Melissa Parkin; Rachel Barry; Wendy Winslow; Claire Healy; Robert R Graham; Benjamin M Neale; Elena Izmailova; Ronenn Roubenoff; Alexander N Parker; Roberta Glass; Elizabeth W Karlson; Nancy Maher; David A Hafler; David M Lee; Michael F Seldin; Elaine F Remmers; Annette T Lee; Leonid Padyukov; Lars Alfredsson; Jonathan Coblyn; Michael E Weinblatt; Stacey B Gabriel; Shaun Purcell; Lars Klareskog; Peter K Gregersen; Nancy A Shadick; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2007-11-04       Impact factor: 38.330

Review 4.  Towards understanding the pathogenesis of rheumatic fever.

Authors:  J R Carapetis; B J Currie; M F Good
Journal:  Scand J Rheumatol       Date:  1996       Impact factor: 3.641

5.  Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans.

Authors:  Sonja Hillebrandt; Hermann E Wasmuth; Ralf Weiskirchen; Claus Hellerbrand; Hildegard Keppeler; Alexa Werth; Ramin Schirin-Sokhan; Gabriele Wilkens; Andreas Geier; Johann Lorenzen; Jörg Köhl; Axel M Gressner; Siegfried Matern; Frank Lammert
Journal:  Nat Genet       Date:  2005-07-03       Impact factor: 38.330

6.  Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium.

Authors:  S Roberts; S Kosanke; D Jankelow; C M Duran; M W Cunningham
Journal:  J Infect Dis       Date:  2000-12-20       Impact factor: 5.226

7.  TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.

Authors:  Robert M Plenge; Mark Seielstad; Leonid Padyukov; Annette T Lee; Elaine F Remmers; Bo Ding; Anthony Liew; Houman Khalili; Alamelu Chandrasekaran; Leela R L Davies; Wentian Li; Adrian K S Tan; Carine Bonnard; Rick T H Ong; Anbupalam Thalamuthu; Sven Pettersson; Chunyu Liu; Chao Tian; Wei V Chen; John P Carulli; Evan M Beckman; David Altshuler; Lars Alfredsson; Lindsey A Criswell; Christopher I Amos; Michael F Seldin; Daniel L Kastner; Lars Klareskog; Peter K Gregersen
Journal:  N Engl J Med       Date:  2007-09-05       Impact factor: 91.245

8.  An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis.

Authors:  Shinya Tokuhiro; Ryo Yamada; Xiaotian Chang; Akari Suzuki; Yuta Kochi; Tetsuji Sawada; Masakatsu Suzuki; Miyuki Nagasaki; Masahiko Ohtsuki; Mitsuru Ono; Hidehiko Furukawa; Masakazu Nagashima; Shinichi Yoshino; Akihiko Mabuchi; Akihiro Sekine; Susumu Saito; Atsushi Takahashi; Tatsuhiko Tsunoda; Yusuke Nakamura; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2003-11-09       Impact factor: 38.330

9.  Gc-globulin concentrations and C5 haplotype-tagging polymorphisms contribute to variations in serum activity of complement factor C5.

Authors:  Olav Gressner; Ursula Meier; Sonja Hillebrandt; Hermann E Wasmuth; Jörg Köhl; Tilman Sauerbruch; Frank Lammert
Journal:  Clin Biochem       Date:  2007-03-12       Impact factor: 3.281

10.  Rheumatoid arthritis association at 6q23.

Authors:  Wendy Thomson; Anne Barton; Xiayi Ke; Steve Eyre; Anne Hinks; John Bowes; Rachelle Donn; Deborah Symmons; Samantha Hider; Ian N Bruce; Anthony G Wilson; Ioanna Marinou; Ann Morgan; Paul Emery; Angela Carter; Sophia Steer; Lynne Hocking; David M Reid; Paul Wordsworth; Pille Harrison; David Strachan; Jane Worthington
Journal:  Nat Genet       Date:  2007-11-04       Impact factor: 38.330

View more
  2 in total

1.  An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer.

Authors:  Tarik Ghadban; Magdalena Schmidt-Yang; Magdalena Smif; Faik G Uzunoglu; Daniel R Perez; Tung Y Tsui; Alexander T El Gammal; Peter J Erbes; Veacheslav Zilbermints; Ulrich Wellner; Klaus Pantel; Jakob R Izbicki; Yogesh K Vashist
Journal:  J Hum Genet       Date:  2014-10-30       Impact factor: 3.172

2.  Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis.

Authors:  Lihua Zhu; Liang Wang; Xu Wang; Lingling Zhou; Ziwei Liao; Ling Xu; Huixia Wu; Jie Ren; Zhaoxia Li; Lijian Yang; Shaohua Chen; Bo Li; Xiuli Wu; Yi Zhou; Yangqiu Li
Journal:  J Transl Med       Date:  2015-07-05       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.